Log In
Print
BCIQ
Print
Print this Print this
 

Tiazac

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionOnce-daily formulation of the calcium channel blocker diltiazem
Molecular Target Calcium channel
Mechanism of ActionCa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner

Forest Laboratories Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today